Rapid Micro Biosystems In... (RPID)
Rapid Micro Biosystems Statistics
Share Statistics
Rapid Micro Biosystems has 43.03M shares outstanding. The number of shares has increased by 1.26% in one year.
| Shares Outstanding | 43.03M |
| Shares Change (YoY) | 1.26% |
| Shares Change (QoQ) | 0.28% |
| Owned by Institutions (%) | 40.21% |
| Shares Floating | 22.66M |
| Failed to Deliver (FTD) Shares | 101 |
| FTD / Avg. Volume | 0.03% |
Short Selling Information
The latest short interest is 113.59K, so 0.26% of the outstanding shares have been sold short.
| Short Interest | 113.59K |
| Short % of Shares Out | 0.26% |
| Short % of Float | 0.48% |
| Short Ratio (days to cover) | 0.96 |
Valuation Ratios
The PE ratio is -0.61 and the forward PE ratio is -1.83. Rapid Micro Biosystems's PEG ratio is 0.04.
| PE Ratio | -0.61 |
| Forward PE | -1.83 |
| PS Ratio | 1.41 |
| Forward PS | 2 |
| PB Ratio | 0.27 |
| P/FCF Ratio | -0.68 |
| PEG Ratio | 0.04 |
Enterprise Valuation
Rapid Micro Biosystems Inc. has an Enterprise Value (EV) of 14.9M.
| EV / Earnings | -0.28 |
| EV / Sales | 0.66 |
| EV / EBITDA | -0.28 |
| EV / EBIT | -0.26 |
| EV / FCF | -0.32 |
Financial Position
The company has a current ratio of 6.34, with a Debt / Equity ratio of 0.06.
| Current Ratio | 6.34 |
| Quick Ratio | 5.29 |
| Debt / Equity | 0.06 |
| Total Debt / Capitalization | 5.86 |
| Cash Flow / Debt | -6.14 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.44% and return on capital (ROIC) is -45.16%.
| Return on Equity (ROE) | -0.44% |
| Return on Assets (ROA) | -0.37% |
| Return on Capital (ROIC) | -45.16% |
| Revenue Per Employee | $116,678.76 |
| Profits Per Employee | $-271,849.74 |
| Employee Count | 193 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 1.4 |
Taxes
| Income Tax | 31K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 207.14% in the last 52 weeks. The beta is 1.27, so Rapid Micro Biosystems's price volatility has been higher than the market average.
| Beta | 1.27 |
| 52-Week Price Change | 207.14% |
| 50-Day Moving Average | 1.9 |
| 200-Day Moving Average | 1.12 |
| Relative Strength Index (RSI) | 56.15 |
| Average Volume (20 Days) | 297.59K |
Income Statement
In the last 12 months, Rapid Micro Biosystems had revenue of 22.52M and earned -52.47M in profits. Earnings per share was -1.22.
| Revenue | 22.52M |
| Gross Profit | -5.49M |
| Operating Income | -56.56M |
| Net Income | -52.47M |
| EBITDA | -53.76M |
| EBIT | -56.56M |
| Earnings Per Share (EPS) | -1.22 |
Balance Sheet
The company has 24.29M in cash and 7.35M in debt, giving a net cash position of 16.94M.
| Cash & Cash Equivalents | 24.29M |
| Total Debt | 7.35M |
| Net Cash | 16.94M |
| Retained Earnings | -428.38M |
| Total Assets | 105.84M |
| Working Capital | 72.01M |
Cash Flow
In the last 12 months, operating cash flow was -45.08M and capital expenditures -1.84M, giving a free cash flow of -46.93M.
| Operating Cash Flow | -45.08M |
| Capital Expenditures | -1.84M |
| Free Cash Flow | -46.93M |
| FCF Per Share | -1.09 |
Margins
Gross margin is -24.36%, with operating and profit margins of -251.18% and -232.99%.
| Gross Margin | -24.36% |
| Operating Margin | -251.18% |
| Pretax Margin | -232.85% |
| Profit Margin | -232.99% |
| EBITDA Margin | -238.72% |
| EBIT Margin | -251.18% |
| FCF Margin | -208.38% |
Dividends & Yields
RPID does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -40.53% |
| FCF Yield | -36.23% |
Analyst Forecast
The average price target for RPID is $8, which is 165.8% higher than the current price. The consensus rating is "Buy".
| Price Target | $8 |
| Price Target Difference | 165.8% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Scores
| Altman Z-Score | -3.67 |
| Piotroski F-Score | 4 |